Population pharmacokinetics of intravenous and oral panobinostat in patients with hematologic and solid tumors

Purpose The study aimed to characterize the population pharmacokinetics of panobinostat, a pan-deacetylase inhibitor that has demonstrated efficacy in combination with bortezomib and dexamethasone in patients with multiple myeloma.